Herein, we observed that, in women with serum AMH ≥ 15 pmol/l, the follitropin alfa/beta treatment was associated with both a higher number of retrieved oocytes and a higher incidence of OHSS compared to the follitropin delta treatment. Here, AMH is linked to ovarian hyperstimulation syndrome.